Home > Financial Ratios > NEULAND LABORATORIES

NEULAND LABORATORIES
Core EBITDA Growth

    Back to All Ratios
NEULAND LABORATORIES is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for NEULAND LABORATORIES
Please provide your vote to see the results

NEULAND LABORATORIES Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) -27.6568.7394.61-11.1854.02

What is the latest Core EBITDA Growth ratio of NEULAND LABORATORIES ?

The latest Core EBITDA Growth ratio of NEULAND LABORATORIES is -27.65 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar2025-27.65
Mar202468.73
Mar202394.61
Mar2022-11.18
Mar202154.02

How is Core EBITDA Growth of NEULAND LABORATORIES Trending?

Years Core EBITDA Growth % Change
Mar2025 -27.65
Negative
Mar2024 68.73
-27.35
Mar2023 94.61
Positive
Mar2022 -11.18
Negative
Mar2021 54.02 -

Other Financial Ratios of NEULAND LABORATORIES


Compare Core EBITDA Growth ratio of peers of NEULAND LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NEULAND LABORATORIES ₹17,382.7 Cr -5.3% -14.1% 3.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹386,773.0 Cr -6.8% -7.6% -4.7% Stock Analytics
DIVIS LABORATORIES ₹159,540.0 Cr -6.6% -5.8% 4.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹134,529.0 Cr 0.9% 5.7% 27.3% Stock Analytics
CIPLA ₹111,299.0 Cr -4.8% -8.1% -3.9% Stock Analytics
DR REDDYS LABORATORIES ₹97,393.0 Cr -2% -8.8% -12.9% Stock Analytics


NEULAND LABORATORIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
NEULAND LABORATORIES

-5.3%

-14.1%

3.6%

SENSEX

-2%

-2.8%

7.4%


You may also like the below Video Courses